Insights

Clinical Partnerships Leverage Quidel's history of strategic partnerships and acquisitions (Beckman Coulter BNP assay rights, Mesa Biotech acquisition) to position companion diagnostic solutions, integrated testing workflows, and distributor reach that enhance product portfolios and expand market access.

Lyme & Infectious capitalize on their publicized Lyme disease awareness initiatives with Global Lyme Alliance to offer targeted infectious disease testing campaigns, education programs, and point-of-care solutions that align with patient advocacy and preventive care initiatives.

MDx Platform Quidel launched Savanna, their MDx platform; approach sales conversations with integrated molecular diagnostics capabilities, data analytics, and scalable cloud-based workflows to appeal to labs seeking end-to-end diagnostic ecosystems.

Regulatory & ESG Respond to ongoing governance with conflicts minerals reporting and securities litigation context by offering transparent supply chain solutions, compliance tooling, and risk management services that strengthen trust with investors and customers.

Growth Potential With a mid-market to enterprise footprint and a revenue range of tens of millions, target expansion through mid-sized hospital systems and regional labs, offering turnkey diagnostic solutions, service contracts, and integration with existing IT stacks (Azure, Salesforce, SQL Server) to drive adoption and recurring revenue.

Similar companies to Diagnostic Hybrids, Inc.

Diagnostic Hybrids, Inc. Tech Stack

Diagnostic Hybrids, Inc. uses 8 technology products and services including Databricks, AutoCAD, Drupal, and more. Explore Diagnostic Hybrids, Inc.'s tech stack below.

Media & News

Diagnostic Hybrids, Inc.'s Email Address Formats

Diagnostic Hybrids, Inc. uses at least 4 email formats:
Diagnostic Hybrids, Inc. Email FormatsExamplePercentage
First.Last@quidel.comJohn.Doe@quidel.com
55%
FLast@quidel.comJDoe@quidel.com
39%
F.Last@quidel.comJ.Doe@quidel.com
5%
FirstLast@quidel.comJohnDoe@quidel.com
1%

Frequently Asked Questions

What is Diagnostic Hybrids, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Diagnostic Hybrids, Inc.'s official website is quidel.com and has social profiles on LinkedIn.

How much revenue does Diagnostic Hybrids, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Diagnostic Hybrids, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Diagnostic Hybrids, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Diagnostic Hybrids, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Diagnostic Hybrids, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Diagnostic Hybrids, Inc. has approximately 56 employees across 1 continents, including North America. Key team members include Director, International Regulatory Compliance: K. L. Explore Diagnostic Hybrids, Inc.'s employee directory with LeadIQ.

What industry does Diagnostic Hybrids, Inc. belong to?

Minus sign iconPlus sign icon
Diagnostic Hybrids, Inc. operates in the Medical Devices industry.

What technology does Diagnostic Hybrids, Inc. use?

Minus sign iconPlus sign icon
Diagnostic Hybrids, Inc.'s tech stack includes Databricks, AutoCAD, Drupal, OneTrust, Salesforce, Microsoft SQL Server, Azure DevOps and Webex.

What is Diagnostic Hybrids, Inc.'s email format?

Minus sign iconPlus sign icon
Diagnostic Hybrids, Inc.'s email format typically follows the pattern of First.Last@quidel.com. Find more Diagnostic Hybrids, Inc. email formats with LeadIQ.
Diagnostic Hybrids, Inc. logo

Diagnostic Hybrids, Inc.

Medical DevicesUnited States51-200 Employees

Diagnostic Hybrids, Inc. is a United States-based medical equipment manufacturer focused on diagnostic solutions that enable rapid testing for infectious diseases as well as cardiovascular and metabolic conditions, with the goal of supporting point-of-care decision-making. These tests are designed to help healthcare workers quickly identify conditions and initiate treatment, potentially improving patient outcomes and contributing to efficiency in the healthcare system. The company is mid-sized and maintains an online presence at quidel.com.

Operating within the diagnostic healthcare sector, the company fits a market that emphasizes fast, on-site testing and easy integration into patient care workflows. In the broader industry landscape, collaborations among diagnostic firms are not uncommon, such as a 2022 partnership between Quidel Corporation and the Global Lyme Alliance to raise awareness about Lyme disease. The organization is based in the United States, and its primary online portal is quidel.com.

Section iconCompany Overview

Website
quidel.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    Diagnostic Hybrids, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.